Your triglyceride-to-HDL ratio is a number you can pull from an ordinary lipid panel that tends to rise early, while insulin resistance is still silent. Here is what the evidence supports, the units trap that flips its meaning, and where it breaks down.
Short answer: The era of cheap, widely available compounded semaglutide is largely over. Once the FDA declared the semaglutide shortage resolved in February 2025, the legal basis that let pharmacies mass-produce copies of Ozempic and Wegovy disappeared, and through 2025 and 2026 the agency steadily tightened enforcement against telehealth companies still selling it. Compounding hasn’t…
